CSIMarket
 


Atyr Pharma Inc  (LIFE)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Atyr Pharma Inc's Leverage Ratio

LIFE's quarterly Leverage Ratio and Total Liabilities, Equity growth




LIFE Leverage Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Equity Change 18.03 % 49.74 % 19.68 % 18.9 % 42.33 %
Y / Y Total Liabilities Change -55.95 % -52.83 % -44.29 % -38.16 % -39.7 %
Leverage Ratio MRQ 0.11 0.22 0.3 0.32 0.29
Overall Ranking # # # # #
Seq. Equity Change 57.32 % -1.61 % -10.96 % -14.37 % 99.6 %
Seq. Total Liabilities Change -23.32 % -25.32 % -17.34 % -6.96 % -17.88 %



Leverage Ratio first quarter 2021 Comment
Due to repayements of liabilities of -23.32% Atyr Pharma Inc improved Leverage Ratio in first quarter 2021 to 0.11, below company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the first quarter 2021, 47 other companies have achieved lower Leverage Ratio than Atyr Pharma Inc. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are LIFE Customers?
Leverage Ratio first quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 48
Healthcare Sector # 162
Overall Market # 318


Leverage Ratio Statistics
High Average Low
1.62 0.61 0.09
(Dec. 31, 2008)   (Sep 30 2016)




Financial Statements
Atyr Pharma Inc's Equity $ 50 Millions Visit LIFE's Balance sheet
Atyr Pharma Inc's Total Liabilities $ 5 Millions Visit LIFE's Balance sheet
Source of LIFE's Sales Visit LIFE's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMar 31 2021, within Biotechnology & Drugs Industry Leverage RatioMar 31 2021 MRQ Total LiabilitiesMar 31 2021 MRQ Equity
Zymeworks Inc   0.30 $ 112.914  Millions$ 377.145  Millions
Procyon Corp  0.30 $ 0.740  Millions$ 2.479  Millions
Volitionrx Ltd  0.30 $ 9.290  Millions$ 31.219  Millions
Sqz Biotechnologies Company  0.29 $ 48.820  Millions$ 169.285  Millions
Cue Biopharma Inc   0.27 $ 19.052  Millions$ 69.669  Millions
Rubius Therapeutics inc   0.27 $ 81.101  Millions$ 300.983  Millions
Cyclo Therapeutics Inc   0.26 $ 3.787  Millions$ 14.322  Millions
Casi Pharmaceuticals inc   0.26 $ 25.897  Millions$ 100.032  Millions
Urogen Pharma Ltd   0.26 $ 19.722  Millions$ 76.491  Millions
G1 Therapeutics Inc   0.26 $ 63.115  Millions$ 245.443  Millions
Berkeley Lights Inc   0.25 $ 60.585  Millions$ 242.366  Millions
Poseida Therapeutics Inc   0.24 $ 55.264  Millions$ 227.486  Millions
Gritstone Bio Inc   0.24 $ 47.588  Millions$ 199.351  Millions
Repligen Corp  0.24 $ 367.341  Millions$ 1,556.216  Millions
Pulmatrix Inc   0.23 $ 13.204  Millions$ 56.646  Millions
Syndax Pharmaceuticals Inc   0.23 $ 51.467  Millions$ 228.205  Millions
Tracon Pharmaceuticals Inc   0.22 $ 4.499  Millions$ 20.357  Millions
Tg Therapeutics inc   0.21 $ 93.065  Millions$ 445.285  Millions
Eargo Inc   0.20 $ 37.972  Millions$ 185.857  Millions
Aligos Therapeutics Inc   0.20 $ 39.320  Millions$ 195.220  Millions
Capricor Therapeutics Inc   0.20 $ 7.164  Millions$ 36.381  Millions
Fulgent Genetics Inc   0.19 $ 151.508  Millions$ 801.566  Millions
Dbv Technologies S a   0.19 $ 31.856  Millions$ 169.176  Millions
Madrigal Pharmaceuticals Inc   0.19 $ 48.471  Millions$ 260.553  Millions
Cohbar Inc   0.18 $ 2.810  Millions$ 15.796  Millions
Oncocyte Corp  0.18 $ 18.817  Millions$ 106.628  Millions
Surface Oncology Inc   0.17 $ 27.267  Millions$ 159.047  Millions
Kiromic Biopharma Inc   0.17 $ 1.431  Millions$ 8.453  Millions
Homology Medicines Inc  0.17 $ 33.868  Millions$ 200.829  Millions
Vaxart Inc   0.17 $ 29.631  Millions$ 176.235  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GAN's Profile

Stock Price

GAN's Financials

Business Description

Fundamentals

Charts & Quotes

GAN's News

Suppliers

GAN's Competitors

Customers & Markets

Economic Indicators

GAN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071